MASS syndrome
Overview
MASS syndrome is a connective tissue disorder that shares some features with Marfan syndrome, but is considered a distinct clinical entity. The acronym MASS stands for Mitral valve prolapse, Aortic root diameter at the upper limits of normal, Skeletal features, and Skin involvement. It is an autosomal dominant condition, meaning it is inherited in a pattern where only one copy of the altered gene is sufficient to cause the disorder.

Clinical Features
Individuals with MASS syndrome may present with a variety of symptoms, which can include:
- Mitral valve prolapse: A condition where the valve between the heart's left atrium and left ventricle doesn't close properly.
- Aortic root diameter: The aorta may be slightly enlarged, but not to the extent seen in Marfan syndrome.
- Skeletal features: These can include a tall stature, long limbs, and arachnodactyly (long, slender fingers).
- Skin involvement: Skin may be hyperextensible and may show striae (stretch marks).
Genetics
MASS syndrome is caused by mutations in the FBN1 gene, which encodes the protein fibrillin-1. This protein is essential for the formation of elastic fibers found in connective tissue. The condition is inherited in an autosomal dominant manner, meaning a single copy of the mutated gene can cause the syndrome.
Diagnosis
Diagnosis of MASS syndrome is primarily clinical, based on the presence of the characteristic features. Genetic testing can confirm mutations in the FBN1 gene, but this is not always necessary for diagnosis.
Management
Management of MASS syndrome involves regular monitoring of the cardiovascular system, particularly the heart valves and aorta. Patients may require echocardiograms to assess the mitral valve and aortic root. Lifestyle modifications and medications may be recommended to manage symptoms and reduce the risk of complications.
Related Conditions
MASS syndrome is related to other connective tissue disorders, such as:
Related Pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian